Team develops anti-obesity treatment in animal models

First Page		Document Content
Date: 2015-05-27 18:56:17 Obesity Adipose tissue Anti-obesity medication Human nutrition Metabolic syndrome Fatty liver Phosphoinositide 3-kinase inhibitor Leptin Calorie restriction Health Medicine Anatomy		Team develops anti-obesity treatment in animal models Add to Reading List Source URL: medicalxpress.com Download Document from Source Website File Size: 55,63 KB Share Document on Facebook

	First Annual Meeting BOOK OF THE ABSTRACTS COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) Università della Svizzera Italiana – USI – Lugano (CH DocID: 1qn8P - View Document
	Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa DocID: 1qeKO - View Document
	Media Release Basel (Switzerland), May 28, 2015 PIQUR announces positive Phase 1 study results and the start of Phase 2 of PQR309 Study confirms that PQR309 is well tolerated and shows promising signs of DocID: 1oXMN - View Document
	Takeda Oncology Development Pipeline DocID: 1obev - View Document
	Priority Report A Dual Phosphoinositide-3-Kinase A/mTOR Inhibitor Cooperates with Blockade of Epidermal Growth Factor Receptor in PTEN-Mutant Glioma 1,2,3,4 DocID: 1lRFE - View Document